0.1284
price up icon0.16%   0.0002
 
loading
Zomedica Corp stock is traded at $0.1284, with a volume of 4.65M. It is up +0.16% in the last 24 hours and up +6.20% over the past month. Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs. It is also developing ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. The company has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. Zomedica Pharmaceuticals Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
See More
Previous Close:
$0.1282
Open:
$0.1275
24h Volume:
4.65M
Relative Volume:
1.04
Market Cap:
$125.63M
Revenue:
$25.19M
Net Income/Loss:
$-34.53M
P/E Ratio:
-5.5826
EPS:
-0.023
Net Cash Flow:
$-20.62M
1W Performance:
-2.13%
1M Performance:
+6.20%
6M Performance:
-27.05%
1Y Performance:
-24.69%
1-Day Range:
Value
$0.1274
$0.131
1-Week Range:
Value
$0.127
$0.1354
52-Week Range:
Value
$0.117
$0.2285

Zomedica Corp Stock (ZOM) Company Profile

Name
Name
Zomedica Corp
Name
Phone
734-369-2555
Name
Address
100 Phoenix Drive, Suite 190, Ann Arbor, MI
Name
Employee
20
Name
Twitter
@zomedica
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ZOM's Discussions on Twitter

Compare ZOM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ZOM
Zomedica Corp
0.1284 125.63M 25.19M -34.53M -20.62M -0.023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 80.59B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 44.17B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 42.61B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.73B 15.05B -883.30M 1.89B 1.53

Zomedica Corp Stock (ZOM) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-06-23 Initiated Dawson James Buy

Zomedica Corp Stock (ZOM) Latest News

pulisher
Nov 27, 2024

Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - AccessWire

Nov 27, 2024
pulisher
Nov 27, 2024

Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled | ZOM Stock News - StockTitan

Nov 27, 2024
pulisher
Nov 21, 2024

Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa

Nov 21, 2024
pulisher
Nov 20, 2024

Zomedica secures new lease for headquarters expansion - Investing.com

Nov 20, 2024
pulisher
Nov 14, 2024

Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - AccessWire

Nov 14, 2024
pulisher
Nov 14, 2024

Zomedica Launches 18-Minute Equine Insulin Test, Expands TRUFORMA Platform Capabilities | ZOM Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 12, 2024

Johnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) Stock - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Zomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble Financial - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Noble Capital Markets Initiates Equity Research Coverage on Zomedica - WICZ

Nov 12, 2024
pulisher
Nov 12, 2024

Zomedica (ZOM) Launches Noble Capital Markets Coverage to Boost Market Visibility | ZOM Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Zomedica initiated with an Outperform at Noble Capital - TipRanks

Nov 11, 2024
pulisher
Nov 09, 2024

Zomedica Corp. (AMEX:ZOM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 09, 2024

Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada

Nov 09, 2024
pulisher
Nov 09, 2024

Earnings call: Zomedica reports record Q3 revenue, eyes future growth By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 08, 2024

Zomedica stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Zomedica reports record Q3 revenue, eyes future growth - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica’s Revenue Up 10% Amid Global Expansion - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica stock plunges to 52-week low of $0.12 amid market challenges - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Herald Palladium

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica CEO to Present at Sidoti Micro Cap Conference, Showcases Pet Health Innovation | ZOM Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Zomedica Corp Posts Increased Revenue Amid Loss - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Zomedica Announces Third Quarter 2024 Financial Results: Revenue - WICZ

Nov 07, 2024
pulisher
Nov 07, 2024

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - AccessWire

Nov 07, 2024
pulisher
Nov 07, 2024

Zomedica Q3 Revenue Jumps 10%, Diagnostics Surges 38% Despite Wider Losses | ZOM Stock News - StockTitan

Nov 07, 2024
pulisher
Oct 31, 2024

Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India

Oct 31, 2024
pulisher
Oct 24, 2024

ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - AccessWire

Oct 24, 2024
pulisher
Oct 23, 2024

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - AccessWire

Oct 23, 2024
pulisher
Oct 23, 2024

Zomedica stock plunges to 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 15, 2024

Adversity is less terrifying than hope: Zomedica Corp (ZOM) - SETE News

Oct 15, 2024
pulisher
Oct 15, 2024

Stock Market Recap: Zomedica Corp (ZOM) Concludes at 0.13, a -2.01 Surge/Decline - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference - Lelezard

Oct 15, 2024
pulisher
Oct 14, 2024

Zomedica Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

Oct 14, 2024
pulisher
Oct 11, 2024

Zomedica Corp [ZOM] stock Initiated by Dawson James analyst, price target now $6 - The DBT News

Oct 11, 2024
pulisher
Oct 10, 2024

Daily Market Movement: Zomedica Corp (ZOM) Sees a -0.46 Decrease, Closing at 0.13 - The Dwinnex

Oct 10, 2024
pulisher
Oct 10, 2024

CEO HEATON LARRY C II acquired 100,000 shares of Zomedica Corp [ZOM] - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

What technical indicators reveal about ZOM stock - US Post News

Oct 09, 2024
pulisher
Oct 09, 2024

Zomedica Corp Inc. (ZOM) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Oct 09, 2024
pulisher
Oct 08, 2024

There is no way Zomedica Corp (ZOM) can keep these numbers up - SETE News

Oct 08, 2024
pulisher
Oct 07, 2024

Understanding the Risks of Investing in Zomedica Corp (ZOM) - Knox Daily

Oct 07, 2024
pulisher
Oct 04, 2024

Zomedica expands distribution agreement in Europe with Grovet - MSN

Oct 04, 2024
pulisher
Oct 03, 2024

ZOM’s valuation metrics: A comprehensive analysis - US Post News

Oct 03, 2024
pulisher
Oct 03, 2024

Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach - Benzinga

Oct 03, 2024
pulisher
Oct 03, 2024

Zomedica Corp (ZOM) Stock: A Year of Decreases and Increases - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe - Herald Palladium

Oct 03, 2024

Zomedica Corp Stock (ZOM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Cap:     |  Volume (24h):